Co-infection of COVID-19 patients with atypical bacteria: A study based in Jordan.

Beisan A Mohammad Luai Z Hasoun Heba A KhaderMahmoud S Abu-SamakLaith Mh Al-ShdifatBasheer Al-ShammariMohammed Al Maqbali

Published in: Pharmacy practice (2022)

In this first study based in Jordan, patients infected with COVID-19 have a low rate of atypical bacterial co-infection. However, clinicians should suspect co-infections with both common and uncommon bacteria in COVID-19 patients. Large prospective investigations are needed to give additional insight on the true prevalence of these co-infections and their impact on the clinical course of COVID-19 patients.

Keyphrases

sars cov
end stage renal disease
newly diagnosed
ejection fraction
coronavirus disease
prognostic factors
risk factors
palliative care
patient reported